Last reviewed · How we verify

NCT04867499

Epidemiology of Acute Mesenteric Ischemia

Completed Last updated 15 March 2022
What this trial tests

trial testing No intervention in Acute Mesenteric Ischemia in 577 participants. Completed in 1 February 2022.

Timeline
5 October 2021
Primary endpoint
1 February 2022
1 February 2022

Quick facts

Lead sponsorTartu University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment577
Start date5 October 2021
Primary completion1 February 2022
Estimated completion1 February 2022
Sites1 location across Estonia

Drugs / interventions tested

Conditions studied

Sponsor

Tartu University Hospital

Who can join

18 and older, any sex, with Acute Mesenteric Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective population-based study on epidemiology of acute mesenteric ischemia in Estonia Study objective is to describe epidemiologic features in adult patients with acute mesenteric ischemia during years 2016-2020. Patients from all hospitals in Estonia are included.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Epidemiology of Acute Mesenteric Ischemia: A Population-Based Investigation.
    Kase K, Reintam Blaser A, Tamme K, Mändul M, et al · · 2023 · cited 33× · PMID 36261602 · DOI 10.1007/s00268-022-06805-5

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Acute Mesenteric Ischemia

Currently open trials in the same condition.

Other Tartu University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04867499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing